Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

1.6%

1 terminated/withdrawn out of 62 trials

Success Rate

96.3%

+9.8% vs industry average

Late-Stage Pipeline

27%

17 trials in Phase 3/4

Results Transparency

8%

2 of 26 completed trials have results

Key Signals

14 recruiting2 with results

Enrollment Performance

Analytics

N/A
19(42.2%)
Phase 3
10(22.2%)
Phase 4
7(15.6%)
Phase 1
6(13.3%)
Phase 2
3(6.7%)
45Total
N/A(19)
Phase 3(10)
Phase 4(7)
Phase 1(6)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (62)

Showing 20 of 62 trials
NCT06687941Phase 1Recruiting

A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors

Role: collaborator

NCT07493668Phase 2Not Yet Recruiting

Fostrox Plus Lenvatinib vs Lenvatinib in Advanced Hepatocellular Carcinoma After First-line Immunotherapy

Role: lead

NCT07142226Recruiting

Role of ctDNA in Genetic Profiling & Outcomes for Advanced BTC

Role: lead

NCT07151118Recruiting

ctDNA in Genetic Profiling and Clinical Outcomes of Advanced Biliary Tract Cancer

Role: lead

NCT06648057Recruiting

Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab

Role: lead

NCT06543082Phase 4Recruiting

MACT (Mono Antiplatelet and Colchicine Therapy) Prospective Multicenter Study

Role: lead

NCT06619353Active Not Recruiting

RCVR (Residual CardioVascular Risk) Prospective Study

Role: lead

NCT07143812Phase 1Recruiting

A Study to Evaluate the Safety of a Stem Cell-Based Gene and Cell Therapy in Patients With Newly Diagnosed Glioblastoma

Role: lead

NCT07027891Not ApplicableRecruiting

The Rule-Out Acute Myocardial Infarction Using Aritifical Intelligence Electrocardiogram (ROMIAE) 2 Trial

Role: lead

NCT04862949Completed

Organ-specific Responses to Atezolizumab Plus Bevacizumab in Advanced HCC

Role: lead

NCT06893380Recruiting

Combination Therapy of GCNT and Tislelizumab in Advanced Biliary Tract Cancer

Role: lead

NCT05197504Completed

Predictive Biomarkers in Patients With Advanced Hepatocellular Carcinoma Treated With Systemic Therapy

Role: lead

NCT04871321Completed

Biomarker Discovery in Patients With Advanced Biliary Tract Cancer

Role: lead

NCT07099807Not ApplicableCompleted

Carbohydrate Mouth Rinsing and Cognitive Response During Exercise

Role: lead

NCT05136560Phase 1Recruiting

Safety and Efficacy of Early Administration of Dexamethasone in High-risk Sepsis

Role: lead

NCT06985693Not ApplicableRecruiting

Medipixel XA-Assisted PCI in Coronary Artery Disease

Role: lead

NCT05421650Not ApplicableRecruiting

Therapeutic Effect of Surgical Debulking of Metastatic Lymph Nodes in Cervical Cancer Stage IIICr

Role: lead

NCT06078592Phase 4Completed

Comparison of Efficacy and Ocular Surface Assessment Between BRIDIN-plus and Combigan in Glaucoma or Ocular Hypertensive

Role: lead

NCT06889818Recruiting

Korean Joint Registry for Alzheimer's Treatment and Diagnostics (JOY-ALZ)

Role: collaborator

NCT06815042Phase 4Not Yet Recruiting

The Analysis of Efficacy Factors for Autologous Platelet-Rich Plasma Therapy in the Treatment of Elbow Tendinopathy

Role: lead